A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease

被引:119
作者
Grove, Erik Lerkevang [1 ]
Hvas, Anne-Mette [2 ]
Johnsen, Helle Ladefoged [1 ]
Hedegaard, Sofie Sommer [1 ]
Pedersen, Susanne Bendesgaard [1 ]
Mortensen, Jette [1 ]
Kristensen, Steen Dalby [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus, Denmark
关键词
Aspirin; aspirin resistance; cardiology; platelet function tests; thromboxanes; LIGHT TRANSMISSION AGGREGOMETRY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; POSITION PAPER; WORKING GROUP; RISK-FACTORS; WHOLE-BLOOD; RESISTANCE; AGGREGATION;
D O I
10.1160/TH09-08-0527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individualised antiplatelet therapy and platelet function testing have attracted considerable clinical interest, but several aspects of test performance have not been thoroughly evaluated, We investigated repeatability and concordance of light transmission aggregometry (LTA) induced with arachidonic acid (AA) 1.0 mM, PFA-100((R)) induced with collagen/epinephrine, multiple electrode aggregometry (MEA) induced with AA 0.5 or 0.75 mM and VerifyNow((R)) Aspirin. Patients with stable coronary artery disease (n=43) and healthy individuals (n=21) were included. All tests were performed in duplicate at baseline in healthy individuals and in duplicate for four days in all study participants during aspirin treatment. Serum and urinary thromboxane metabolites were measured several times to evaluate cyclooxygenase-1 inhibition by aspirin. MEA was most sensitive for aspirin as treatment induced a 12-fold difference in AA-induced platelet aggregation. Coefficients of variation for duplicate measurements at baseline (0.4-12%), during aspirin treatment (3-46%) and for day-to-day variability (3-37%) differed markedly between tests and were lowest for VerifyNow((R)). The prevalence of aspirin low-responsiveness also differed between tests (0-9%) and the agreement was low: kappa <= 0.21 for all tests compared with AA-induced LTA (reference test), which correlated best with VerifyNow((R)) (r=0.43, p<0.001). Urinary thromboxane metabolites did not correlate with any platelet function test, whereas serum thromboxane correlated with VerifyNow((R)) Aspirin (r=0.41, p=0.001). Overall, repeatability was moderate and the correlation between tests was low. VerifyNow((R)) Aspirin proved most reproducible, and this was the only assay showing a significant positive correlation with serum thromboxane. This study demonstrated that conclusions based on platelet function testing strongly depend on the assay used.
引用
收藏
页码:1245 / 1253
页数:9
相关论文
共 47 条
[1]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[2]   Response to aspirin in healthy individuals Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B2 [J].
Blais, Normand ;
Pharand, Chantal ;
Lordkipanidze, Marie ;
Sia, Ying K. ;
Merhi, Yahye ;
Diodati, Jean G. .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) :404-411
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]  
BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
[5]   Variation in Platelet Function Testing Has a Major Influence on Detection of Aspirin Resistance in Healthy Subjects [J].
Bozic-Mijovski, Mojca ;
Rakusa, Matej ;
Stegnar, Mojca .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (02) :84-90
[6]   PAIRED ANALYSIS OF URINARY THROMBOXANE-B2 METABOLITES IN HUMANS [J].
CATELLA, F ;
FITZGERALD, GA .
THROMBOSIS RESEARCH, 1987, 47 (06) :647-656
[7]   Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance [J].
Cattaneo, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :1980-1987
[8]   Laboratory detection of 'aspirin resistance': what test should we use (if any)? [J].
Cattaneo, Marco .
EUROPEAN HEART JOURNAL, 2007, 28 (14) :1673-1675
[9]   Aspirin resistance and adverse clinical events in patients with coronary artery disease [J].
Chen, Wai-Hong ;
Cheng, Xi ;
Lee, Pui-Yin ;
Ng, William ;
Kwok, Jeanette Yat-Yin ;
Tse, Hung-Fat ;
Lau, Chu-Pak .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (07) :631-635
[10]   Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment [J].
Chen, WH ;
Lee, PY ;
Ng, W ;
Tse, HF ;
Lau, CP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :1122-1126